October 15, 2024
Alliance A032102: PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)
Overview: Rana McKay, MD, of University of California San Diego Health, leads Alliance A032102 (PREDICT) - a phase II trial to evaluate whether genetic testing in prostate cancer is helpful in deciding which study treatment patients are assigned. Patient cancer tissue samples are obtained from a previous surgery or biopsy proc
October 7, 2024
The Alliance Office of the Group Chair, and Alliance Chicago, Boston, and Duke Offices will be closed on Monday, October 14 in observance of the National Indigenous Peoples/Columbus Day holiday. The Alliance Statistics and Data Management Center, most Alliance Biorepositories, and McKesson's Clinical Research Services will remain open on Monday, October 14. For specific details, review the BioMS
October 3, 2024
The Alliance Board of Directors has appointed Kimberly F. Kerstann, PhD, as Chief Operating Officer of the Alliance for Clinical Trials in Oncology, effective November 11, 2024. She is currently serving as the Chief Administrative Officer of the Winship Cancer Institute of Emory University, a large multidisciplinary NCI-designated comprehensive cancer center and clinical practice. Dr. Kerstann brings an impressiv
